PRECIPIO, INC. Gains (Losses) on Restructuring of Debt
PRECIPIO, INC. (PRPO) reported Gains (Losses) on Restructuring of Debt of $1.18 million for the 12-month period ending 2017-12-31, per its 10-K filed 2019-04-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnRestructuringOfDebt · last filed 2019-04-16
- PRECIPIO, INC. gains (losses) on restructuring of debt for fiscal 2017 was $1.18M.
| Period end | Gains (Losses) on Restructuring of Debt 12 month |
|---|---|
| 2017-12-31 | $1.18M 10-K · filed 2019-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |